Glumetinib
C-Met Exon 14 Mutation
Haihe Biopharma Co., Ltd.Phase 1/2
—
Rating in progress
Glumetinib in C-Met Exon 14 Mutation is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active